Device
MGH OFDI Imaging
MGH OFDI Imaging is a medical device with 2 clinical trials. Historical success rate of 100.0%.
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Completed(2)
Detailed Status
Completed2
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed2100%
Recent Activity
Clinical Trials (2)
Showing 2 of 2 trials
NCT01439594Not Applicable
Optical Frequency Domain Imaging (OFDI) Assessment in Radiofrequency Ablation
NCT01439035Not Applicable
Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Young Adults
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2